ANGELA SMUTNY: Open Payments
NPI 1174829220 · NORFOLK, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$562 in 32 payments from 7 companies in 2025. Trend: 2023 $661 · 2024 $459 · 2025 $562
Food & beverage: $562
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 8 | $160 |
| AstraZeneca Pharmaceuticals LP | 7 | $145 |
| Novo Nordisk Inc | 9 | $139 |
| ABBVIE INC. | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Astellas Pharma US Inc | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 2 | $12 |
Products named: REXULTI, Ozempic, FARXIGA, AIRSUPRA, QULIPTA, Kerendia, Wegovy, Veozah.
Industry payments across NE — which companies pay providers there.
